Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Gennova’s m RNA vaccine gets clearance for Phase 2/3 clinical trials,

The company began Phase 1 trial in April. HGCO19’s development is being supported by central government’s Department of Biotechnology-Biotechnology Industry Research Assistance Council (DBT-BIRAC)., The company began Phase 1 trial in April. HGCO19’s development is being supported by central government’s Department of Biotechnology-Biotechnology Industry Research Assistance Council (DBT-BIRAC)., Read More

Scroll to Top